Skip to content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigen-specific IgA seropositive population

^Deceased
BMC Cancer201818:9

https://doi.org/10.1186/s12885-017-3718-2

Received: 28 July 2017

Accepted: 30 October 2017

Published: 2 January 2018

Back to article

Open Peer Review reports

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
28 Jul 2017 Submitted Original manuscript
7 Aug 2017 Author responded Author comments - Minjie Mao
Resubmission - Version 2
7 Aug 2017 Submitted Manuscript version 2
27 Aug 2017 Reviewed Reviewer Report - Lei Tao
27 Aug 2017 Reviewed Reviewer Report - Yasuaki Harabuchi
13 Sep 2017 Author responded Author comments - Minjie Mao
Resubmission - Version 3
13 Sep 2017 Submitted Manuscript version 3
27 Sep 2017 Author responded Author comments - Minjie Mao
Resubmission - Version 4
27 Sep 2017 Submitted Manuscript version 4
23 Oct 2017 Author responded Author comments - Minjie Mao
Resubmission - Version 5
23 Oct 2017 Submitted Manuscript version 5
Publishing
30 Oct 2017 Editorially accepted
2 Jan 2018 Article published 10.1186/s12885-017-3718-2

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Laboratory Medicine, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
(2)
Department of Laboratory Medicine, Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou, China
(3)
Guangdong Medical University, Guangzhou, China

Advertisement